BIOTON S.A. (WSE:BIO)
Poland · Delayed Price · Currency is PLN 3.985
+0.005 (0.13%)
Jun 16, 2026, 4:12 PM CET
BIOTON Market Cap
BIOTON has a market cap or net worth of 341.74 million as of June 16, 2026. Its market cap has decreased by -4.10% in one year.
Market Cap
341.74M
Enterprise Value
397.87M
Revenue
266.02M
Ranking
n/a
PE Ratio
84.50
Stock Price
3.99
Market Cap Chart
Since July 1, 2005, BIOTON's market cap has decreased from 1.09B to 341.74M, a decrease of -68.74%. That is a compound annual growth rate of -5.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 341.74M | 3.11% |
| Dec 30, 2025 | 331.44M | 33.80% |
| Dec 30, 2024 | 247.72M | -19.19% |
| Dec 29, 2023 | 306.54M | 5.93% |
| Dec 30, 2022 | 289.36M | -19.47% |
| Dec 30, 2021 | 359.34M | -2.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 501.28M |
| Bioceltix | 495.14M |
| Ryvu Therapeutics | 355.59M |
| Syn2bio | 287.54M |
| Synthaverse | 208.37M |
| Molecure | 117.44M |
| Mabion | 115.88M |
| Poltreg | 114.48M |